Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study

scientific article published on 19 January 2009

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHN598
P698PubMed publication ID19153178
P5875ResearchGate publication ID23800894

P50authorThomas MünzelQ1319467
Till KellerQ47502713
Stergios TzikasQ50982462
Philipp S WildQ87613576
Dirk PeetzQ97522394
Laurence TiretQ114312351
Viviane NicaudQ114334738
Hans-Jürgen RupprechtQ114444128
Edith LubosQ114577377
Christoph BickelQ114577378
Renate B. SchnabelQ21264509
Stefan BlankenbergQ28039327
P2093author name stringKarl J Lackner
Claudia Martina Messow
P2860cites workPrognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Q48278579
Applicability of estimated glomerular filtration rate in stratifying chronic kidney diseaseQ51755887
Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients.Q51924362
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunctionQ52081068
N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal functionQ77513199
Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery DiseaseQ24298273
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul StudyQ24646339
Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patientsQ28193844
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarctionQ28213597
Cystatin C and the risk of death and cardiovascular events among elderly personsQ28251528
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalizationQ28283679
Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndromeQ28287352
Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature reviewQ28293020
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rateQ28295117
Serum cystatin C concentration as a marker of renal dysfunction in the elderlyQ31794722
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventiQ34272627
Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney diseaseQ34561358
Renal disease in cardiovascular disorders: an underrecognized problemQ36077720
How to estimate GFR-serum creatinine, serum cystatin C or equations?Q36711754
Chronic kidney disease: effects on the cardiovascular systemQ36868237
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) StudyQ40308364
Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.Q40458738
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart diseaseQ43723152
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination SurveyQ44261213
A population-based study of the incidence and outcomes of diagnosed chronic kidney diseaseQ44603637
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart diseaseQ45270066
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition studyQ46783054
Impact of renal dysfunction on 1-year mortality after acute myocardial infarctionQ46965932
P433issue3
P921main subjectpatientQ181600
coronary artery diseaseQ844935
artery diseaseQ18965518
P304page(s)314-320
P577publication date2009-01-19
P1433published inEuropean Heart JournalQ2286839
P1476titleCystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study
P478volume30

Reverse relations

cites work (P2860)
Q57070928Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis
Q43640737British Society of Heart Failure 2009 meeting report
Q42343601Clinical application of simultaneous detection of cystatin C, cathepsin S, and IL-1 in classification of coronary artery disease
Q36265357Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome
Q30276065Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study
Q53649793Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome
Q51621252Cystatin C estimated renal dysfunction predicts T wave axis deviation in US adults: results from NHANES III
Q58121766Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome
Q49041943Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients
Q37856794Cystatin C: a step forward in assessing kidney function and cardiovascular risk
Q22306345Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association
Q22306356Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association
Q22241921Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association
Q29547236Heart disease and stroke statistics--2011 update: a report from the American Heart Association
Q29547909Heart disease and stroke statistics--2012 update: a report from the American Heart Association
Q29547691Heart disease and stroke statistics--2014 update: a report from the American Heart Association
Q35032801Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease.
Q57448723Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty
Q35020305Improving Prognosis Estimation in Patients with Heart Failure and the Cardiorenal Syndrome
Q55086491Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances.
Q37836492Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes.
Q33904523Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients
Q38651014Lack of association between cystatin C and different coronary atherosclerotic manifestations.
Q86978330Male Gender and Body Mass Index Are Associated With Hypertension and Reduced Kidney Function 5 or More Years After Living Kidney Donation
Q38864815Novel biomarkers with potential for cardiovascular risk reclassification
Q97681474Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain
Q53349759Potentials of cystatin C and uric acid for predicting prognosis of heart failure
Q59049724Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography
Q37878492Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target
Q42736998Response: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100).
Q35686023Risk Factors of Coronary Artery Disease in Secondary Prevention--Results from the AtheroGene--Study
Q58121740Role for Cystatin C-Based Risk Stratification for Patients After Acute Coronary Syndrome in the Era of High Sensitivity Cardiac Troponin Assays
Q92911797Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions
Q92340460Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
Q48325689Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction
Q44436983Usefulness of β-Trace Protein and Cystatin C for the Prediction of Mortality in Non ST Segment Elevation Acute Coronary Syndromes

Search more.